{"id":"https://openalex.org/W1849035610","doi":"https://doi.org/10.1158/1078-0432.ccr-15-0211","title":"Maintenance Treatment with Cetuximab and BAY86-9766 Increases Antitumor Efficacy of Irinotecan plus Cetuximab in Human Colorectal Cancer Xenograft Models","display_name":"Maintenance Treatment with Cetuximab and BAY86-9766 Increases Antitumor Efficacy of Irinotecan plus Cetuximab in Human Colorectal Cancer Xenograft Models","alternate_titles":[],"publication_year":2015,"publication_date":"2015-09-14","ids":{"openalex":"https://openalex.org/W1849035610","doi":"https://doi.org/10.1158/1078-0432.ccr-15-0211","mag":"1849035610","pmid":"https://pubmed.ncbi.nlm.nih.gov/26019172"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-15-0211","doi":"https://doi.org/10.1158/1078-0432.ccr-15-0211","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-15-0211","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1849035610"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020655022","display_name":"Teresa Troiani","orcid":"https://orcid.org/0000-0002-0646-4901","observed_orcids":["https://orcid.org/0000-0002-0646-4901"]},"institutions":[{"id":"https://openalex.org/I197809005","display_name":"University of Campania \"Luigi Vanvitelli\"","ror":"https://ror.org/02kqnpp86","country_code":"IT","type":"education","lineage":["https://openalex.org/I197809005"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Teresa Troiani","raw_affiliation_strings":["1Oncologia Medica, Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale \u201cF. Magrassi e A. Lanzara,\u201d Seconda Universit\u00e0 degli Studi di Napoli, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncologia Medica, Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale \u201cF. Magrassi e A. Lanzara,\u201d Seconda Universit\u00e0 degli Studi di Napoli, Naples, Italy","institution_ids":["https://openalex.org/I197809005"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004016643","display_name":"Stefania Napolitano","orcid":"https://orcid.org/0000-0003-3504-8349","observed_orcids":["https://orcid.org/0000-0003-3504-8349"]},"institutions":[{"id":"https://openalex.org/I197809005","display_name":"University of Campania \"Luigi Vanvitelli\"","ror":"https://ror.org/02kqnpp86","country_code":"IT","type":"education","lineage":["https://openalex.org/I197809005"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stefania Napolitano","raw_affiliation_strings":["1Oncologia Medica, Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale \u201cF. Magrassi e A. Lanzara,\u201d Seconda Universit\u00e0 degli Studi di Napoli, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncologia Medica, Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale \u201cF. Magrassi e A. Lanzara,\u201d Seconda Universit\u00e0 degli Studi di Napoli, Naples, Italy","institution_ids":["https://openalex.org/I197809005"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076690603","display_name":"Giulia Martini","orcid":"https://orcid.org/0000-0003-4093-2681","observed_orcids":["https://orcid.org/0000-0003-4093-2681"]},"institutions":[{"id":"https://openalex.org/I197809005","display_name":"University of Campania \"Luigi Vanvitelli\"","ror":"https://ror.org/02kqnpp86","country_code":"IT","type":"education","lineage":["https://openalex.org/I197809005"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Giulia Martini","raw_affiliation_strings":["1Oncologia Medica, Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale \u201cF. Magrassi e A. Lanzara,\u201d Seconda Universit\u00e0 degli Studi di Napoli, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncologia Medica, Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale \u201cF. Magrassi e A. Lanzara,\u201d Seconda Universit\u00e0 degli Studi di Napoli, Naples, Italy","institution_ids":["https://openalex.org/I197809005"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006208754","display_name":"Erika Martinelli","orcid":"https://orcid.org/0000-0002-0291-475X","observed_orcids":["https://orcid.org/0000-0002-0291-475X"]},"institutions":[{"id":"https://openalex.org/I197809005","display_name":"University of Campania \"Luigi Vanvitelli\"","ror":"https://ror.org/02kqnpp86","country_code":"IT","type":"education","lineage":["https://openalex.org/I197809005"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Erika Martinelli","raw_affiliation_strings":["1Oncologia Medica, Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale \u201cF. Magrassi e A. Lanzara,\u201d Seconda Universit\u00e0 degli Studi di Napoli, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncologia Medica, Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale \u201cF. Magrassi e A. Lanzara,\u201d Seconda Universit\u00e0 degli Studi di Napoli, Naples, Italy","institution_ids":["https://openalex.org/I197809005"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011531470","display_name":"Claudia Cardone","orcid":"https://orcid.org/0000-0003-4502-1932","observed_orcids":["https://orcid.org/0000-0003-4502-1932"]},"institutions":[{"id":"https://openalex.org/I197809005","display_name":"University of Campania \"Luigi Vanvitelli\"","ror":"https://ror.org/02kqnpp86","country_code":"IT","type":"education","lineage":["https://openalex.org/I197809005"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Claudia Cardone","raw_affiliation_strings":["1Oncologia Medica, Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale \u201cF. Magrassi e A. Lanzara,\u201d Seconda Universit\u00e0 degli Studi di Napoli, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncologia Medica, Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale \u201cF. Magrassi e A. Lanzara,\u201d Seconda Universit\u00e0 degli Studi di Napoli, Naples, Italy","institution_ids":["https://openalex.org/I197809005"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003014678","display_name":"Nicola Normanno","orcid":"https://orcid.org/0000-0002-7158-2605","observed_orcids":["https://orcid.org/0000-0002-7158-2605"]},"institutions":[{"id":"https://openalex.org/I4210141868","display_name":"Istituto Nazionale Tumori IRCCS \"Fondazione G. Pascale\"","ror":"https://ror.org/0506y2b23","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210141868","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nicola Normanno","raw_affiliation_strings":["2Cell Biology and Biotherapy Unit, National Cancer Institute \u201cFondazione Giovanni Pascale,\u201d Naples, Italy","3Pharmacogenomic Laboratory, INT-Fondazione Pascale-Centro di Ricerche Oncologiche di Mercogliano (CROM), Mercogliano (AV), Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Cell Biology and Biotherapy Unit, National Cancer Institute \u201cFondazione Giovanni Pascale,\u201d Naples, Italy","institution_ids":["https://openalex.org/I4210141868"]},{"raw_affiliation_string":"3Pharmacogenomic Laboratory, INT-Fondazione Pascale-Centro di Ricerche Oncologiche di Mercogliano (CROM), Mercogliano (AV), Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024015438","display_name":"Donata Vitagliano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I197809005","display_name":"University of Campania \"Luigi Vanvitelli\"","ror":"https://ror.org/02kqnpp86","country_code":"IT","type":"education","lineage":["https://openalex.org/I197809005"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Donata Vitagliano","raw_affiliation_strings":["1Oncologia Medica, Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale \u201cF. Magrassi e A. Lanzara,\u201d Seconda Universit\u00e0 degli Studi di Napoli, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncologia Medica, Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale \u201cF. Magrassi e A. Lanzara,\u201d Seconda Universit\u00e0 degli Studi di Napoli, Naples, Italy","institution_ids":["https://openalex.org/I197809005"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012201620","display_name":"Floriana Morgillo","orcid":"https://orcid.org/0000-0002-9167-323X","observed_orcids":["https://orcid.org/0000-0002-9167-323X"]},"institutions":[{"id":"https://openalex.org/I197809005","display_name":"University of Campania \"Luigi Vanvitelli\"","ror":"https://ror.org/02kqnpp86","country_code":"IT","type":"education","lineage":["https://openalex.org/I197809005"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Floriana Morgillo","raw_affiliation_strings":["1Oncologia Medica, Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale \u201cF. Magrassi e A. Lanzara,\u201d Seconda Universit\u00e0 degli Studi di Napoli, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncologia Medica, Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale \u201cF. Magrassi e A. Lanzara,\u201d Seconda Universit\u00e0 degli Studi di Napoli, Naples, Italy","institution_ids":["https://openalex.org/I197809005"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039134651","display_name":"Francesca Fenizia","orcid":"https://orcid.org/0000-0003-0523-1919","observed_orcids":["https://orcid.org/0000-0003-0523-1919"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Francesca Fenizia","raw_affiliation_strings":["3Pharmacogenomic Laboratory, INT-Fondazione Pascale-Centro di Ricerche Oncologiche di Mercogliano (CROM), Mercogliano (AV), Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Pharmacogenomic Laboratory, INT-Fondazione Pascale-Centro di Ricerche Oncologiche di Mercogliano (CROM), Mercogliano (AV), Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002867055","display_name":"Matilde Lambiase","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Matilde Lambiase","raw_affiliation_strings":["3Pharmacogenomic Laboratory, INT-Fondazione Pascale-Centro di Ricerche Oncologiche di Mercogliano (CROM), Mercogliano (AV), Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Pharmacogenomic Laboratory, INT-Fondazione Pascale-Centro di Ricerche Oncologiche di Mercogliano (CROM), Mercogliano (AV), Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051072215","display_name":"Luigi Formisano","orcid":"https://orcid.org/0000-0001-7205-5105","observed_orcids":["https://orcid.org/0000-0001-7205-5105"]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Luigi Formisano","raw_affiliation_strings":["4Oncologia Medica, Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Universit\u00e0 di Napoli Federico II, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Oncologia Medica, Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Universit\u00e0 di Napoli Federico II, Naples, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040413764","display_name":"Roberto Bianco","orcid":"https://orcid.org/0000-0003-3311-260X","observed_orcids":["https://orcid.org/0000-0003-3311-260X"]},"institutions":[{"id":"https://openalex.org/I71267560","display_name":"University of Naples Federico II","ror":"https://ror.org/05290cv24","country_code":"IT","type":"education","lineage":["https://openalex.org/I71267560"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Roberto Bianco","raw_affiliation_strings":["4Oncologia Medica, Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Universit\u00e0 di Napoli Federico II, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Oncologia Medica, Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Universit\u00e0 di Napoli Federico II, Naples, Italy","institution_ids":["https://openalex.org/I71267560"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047539709","display_name":"Davide Ciardiello","orcid":"https://orcid.org/0000-0003-1826-0305","observed_orcids":["https://orcid.org/0000-0003-1826-0305"]},"institutions":[{"id":"https://openalex.org/I197809005","display_name":"University of Campania \"Luigi Vanvitelli\"","ror":"https://ror.org/02kqnpp86","country_code":"IT","type":"education","lineage":["https://openalex.org/I197809005"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Davide Ciardiello","raw_affiliation_strings":["1Oncologia Medica, Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale \u201cF. Magrassi e A. Lanzara,\u201d Seconda Universit\u00e0 degli Studi di Napoli, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncologia Medica, Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale \u201cF. Magrassi e A. Lanzara,\u201d Seconda Universit\u00e0 degli Studi di Napoli, Naples, Italy","institution_ids":["https://openalex.org/I197809005"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056034569","display_name":"Fortunato Ciardiello","orcid":"https://orcid.org/0000-0002-3369-4841","observed_orcids":["https://orcid.org/0000-0002-3369-4841"]},"institutions":[{"id":"https://openalex.org/I197809005","display_name":"University of Campania \"Luigi Vanvitelli\"","ror":"https://ror.org/02kqnpp86","country_code":"IT","type":"education","lineage":["https://openalex.org/I197809005"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fortunato Ciardiello","raw_affiliation_strings":["1Oncologia Medica, Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale \u201cF. Magrassi e A. Lanzara,\u201d Seconda Universit\u00e0 degli Studi di Napoli, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Oncologia Medica, Dipartimento Medico-Chirurgico di Internistica Clinica e Sperimentale \u201cF. Magrassi e A. Lanzara,\u201d Seconda Universit\u00e0 degli Studi di Napoli, Naples, Italy","institution_ids":["https://openalex.org/I197809005"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.9256,"has_fulltext":false,"cited_by_count":26,"citation_normalized_percentile":{"value":0.74397099,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"21","issue":"18","first_page":"4153","last_page":"4164"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.9869999885559082},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.9110000133514404},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.8119999766349792},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.8519999980926514},{"id":"https://openalex.org/keywords/egfr-inhibitors","display_name":"EGFR inhibitors","score":0.7229999899864197},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.8399999737739563},{"id":"https://openalex.org/keywords/regorafenib","display_name":"regorafenib","score":0.8169999718666077},{"id":"https://openalex.org/keywords/pik3ca-inhibitors","display_name":"PIK3CA inhibitors","score":0.972000002861023},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.7770000100135803},{"id":"https://openalex.org/keywords/kras-mutation","display_name":"KRAS mutation","score":0.9480000138282776},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.9440000057220459},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.7820000052452087},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.4410000145435333}],"concepts":[{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.9894317388534546},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.8794935941696167},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8299837112426758},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.7783623337745667},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.6927566528320312},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.5130609273910522},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4956308603286743},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4770885407924652},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.438279390335083},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.4367362856864929},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4263773560523987},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.4100702404975891},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.4010235369205475},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.38215136528015137},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3661181926727295},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.22015637159347534},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.07347935438156128},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068818","descriptor_name":"Cetuximab","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000077146","descriptor_name":"Irinotecan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004159","descriptor_name":"Diphenylamine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004159","descriptor_name":"Diphenylamine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D019869","descriptor_name":"Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020930","descriptor_name":"MAP Kinase Kinase Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D020935","descriptor_name":"MAP Kinase Signaling System","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058534","descriptor_name":"Class I Phosphatidylinositol 3-Kinases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.ccr-15-0211","doi":"https://doi.org/10.1158/1078-0432.ccr-15-0211","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-15-0211","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:26019172","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26019172","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"pmh:oai:iris.unicampania.it:11591/327240","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11591/327240","pdf_url":null,"source":{"id":"https://openalex.org/S7407055255","display_name":"Archivio Istituzionale della Ricerca - Universit\u00e0 degli Studi della Campania \"Luigi Vanvitelli\"","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W1504814099","https://openalex.org/W1968209756","https://openalex.org/W1981804005","https://openalex.org/W1987443121","https://openalex.org/W1997303727","https://openalex.org/W2005348280","https://openalex.org/W2006168411","https://openalex.org/W2007513598","https://openalex.org/W2027371008","https://openalex.org/W2041919461","https://openalex.org/W2044468942","https://openalex.org/W2048733292","https://openalex.org/W2058983261","https://openalex.org/W2062109911","https://openalex.org/W2065920166","https://openalex.org/W2085633477","https://openalex.org/W2097121246","https://openalex.org/W2100490225","https://openalex.org/W2100589633","https://openalex.org/W2100968040","https://openalex.org/W2109387929","https://openalex.org/W2112570485","https://openalex.org/W2116731538","https://openalex.org/W2119746400","https://openalex.org/W2124003148","https://openalex.org/W2133129337","https://openalex.org/W2134519717","https://openalex.org/W2135118349","https://openalex.org/W2141630197","https://openalex.org/W2142564546","https://openalex.org/W2143574474","https://openalex.org/W2145854263","https://openalex.org/W2147297736","https://openalex.org/W2147834058","https://openalex.org/W2150575159","https://openalex.org/W2150625137","https://openalex.org/W2150840254","https://openalex.org/W2161479438","https://openalex.org/W2162247266","https://openalex.org/W2164837623","https://openalex.org/W2165091551","https://openalex.org/W2167341633","https://openalex.org/W2171237493","https://openalex.org/W2326149323","https://openalex.org/W4317613976"],"related_works":["https://openalex.org/W2100968040","https://openalex.org/W2309999272","https://openalex.org/W2146037607","https://openalex.org/W2072873806","https://openalex.org/W2999034871","https://openalex.org/W2143574474","https://openalex.org/W2274027958","https://openalex.org/W41788149","https://openalex.org/W2006216255","https://openalex.org/W2203184642"],"abstract_inverted_index":{"PURPOSE:":[0],"The":[1,83,144],"use":[2],"of":[3,8,16,26,38,90,119,139,156,170,184,204,211],"cetuximab":[4,145,193,243],"in":[5,23,47,98,103,191,209,218,234],"the":[6,36,120,137,150,185,192,219],"treatment":[7,53,85,108,148,249],"metastatic":[9,235],"colorectal":[10,33,65,236],"cancer":[11,34,66,237],"is":[12,238],"limited":[13],"by":[14,175,182],"development":[15],"resistance.":[17],"EXPERIMENTAL":[18],"DESIGN:":[19],"We":[20],"have":[21],"investigated":[22],"three":[24,100],"models":[25,102],"highly":[27],"epidermal":[28],"growth":[29],"factor":[30],"receptor":[31],"(EGFR)-dependent":[32],"xenografts,":[35],"effect":[37,160],"maintenance":[39,240],"therapy":[40,171,241],"with":[41,49,55,79,109,142,154,214,242,250],"different":[42],"kinase":[43],"inhibitors":[44,233],"alone":[45],"or":[46],"combination":[48,138],"cetuximab,":[50,112,124],"after":[51,105,168,246],"cytotoxic":[52],"induction":[54,107],"irinotecan":[56,80,110,251],"plus":[57,111,146,194,244,252],"cetuximab.":[58,82,143,253],"RESULTS:":[59],"SW48,":[60],"LIM":[61],"1215,":[62],"and":[63,74,172,187],"GEO":[64],"cell":[67],"lines":[68],"were":[69,114,207],"engrafted":[70],"into":[71],"nude":[72],"mice":[73,113],"treated":[75],"for":[76,163],"3":[77],"weeks":[78,167],"and/or":[81,136,228],"combined":[84],"induced":[86],"a":[87,126,131,202,239],"significant":[88],"reduction":[89],"tumor":[91,157],"size.":[92],"A":[93,223],"subsequent":[94],"experiment":[95],"was":[96,161,173,180],"performed":[97],"all":[99],"xenograft":[101,197],"which":[104],"an":[106,247],"randomly":[115],"assigned":[116],"to":[117,165,226,231],"one":[118],"following":[121],"treatments:":[122],"control,":[123],"regorafenib,":[125],"selective":[127,132],"PIK3CA":[128],"inhibitor":[129,134,141],"(PIK3CAi),":[130],"MEK":[133,188],"(MEKi),":[135],"each":[140],"MEKi":[147,245],"determined":[149],"best":[151],"antitumor":[152],"activity":[153,179],"suppression":[155],"growth.":[158],"This":[159],"prolonged":[162,176],"13":[164],"15":[166],"cessation":[169],"accompanied":[174,181],"survival.":[177],"Antitumor":[178],"inhibition":[183],"MAPK":[186],"pathways.":[189],"Moreover,":[190],"MEKi-treated":[195,220],"SW48":[196],"group,":[198],"KRAS":[199,216],"mutations":[200,217],"as":[201],"mechanism":[203],"acquired":[205],"resistance":[206,230],"detected":[208],"25%":[210],"cases":[212],"compared":[213],"75%":[215],"group.":[221],"CONCLUSIONS:":[222],"possible":[224],"strategy":[225],"prevent":[227],"overcome":[229],"anti-EGFR":[232],"initial":[248]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1849035610","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
